MXPA06003464A - Cosmetic deodorant composition comprising a combination of zinc salicylate or a derivative thereof with an aluminium salt antiperspirant active - Google Patents
Cosmetic deodorant composition comprising a combination of zinc salicylate or a derivative thereof with an aluminium salt antiperspirant activeInfo
- Publication number
- MXPA06003464A MXPA06003464A MXPA/A/2006/003464A MXPA06003464A MXPA06003464A MX PA06003464 A MXPA06003464 A MX PA06003464A MX PA06003464 A MXPA06003464 A MX PA06003464A MX PA06003464 A MXPA06003464 A MX PA06003464A
- Authority
- MX
- Mexico
- Prior art keywords
- aluminum
- composition according
- composition
- zirconium
- zinc salicylate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 106
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 38
- PZXFWBWBWODQCS-UHFFFAOYSA-L zinc;2-carboxyphenolate Chemical compound [Zn+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O PZXFWBWBWODQCS-UHFFFAOYSA-L 0.000 title claims abstract description 31
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 230000001166 anti-perspirant Effects 0.000 title claims abstract description 26
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 26
- 159000000013 aluminium salts Chemical class 0.000 title 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 title 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 3
- -1 aluminum zirconium octachloride Chemical compound 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 229910052782 aluminium Inorganic materials 0.000 claims description 21
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 20
- 239000000443 aerosol Substances 0.000 claims description 18
- 235000019645 odor Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000001993 wax Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000004471 Glycine Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 239000003380 propellant Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 claims description 8
- 239000003974 emollient agent Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 230000000844 anti-bacterial Effects 0.000 claims description 5
- 150000002430 hydrocarbons Chemical class 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 239000003899 bactericide agent Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- FMXLGOWFNZLJQK-UHFFFAOYSA-N hypochlorous acid;zirconium Chemical compound [Zr].ClO FMXLGOWFNZLJQK-UHFFFAOYSA-N 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002304 perfume Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000001476 alcoholic Effects 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- YXZZLAMCXFHTTE-UHFFFAOYSA-N aluminum;propane-1,2-diol;trihypochlorite;hydrate Chemical compound O.[Al+3].Cl[O-].Cl[O-].Cl[O-].CC(O)CO YXZZLAMCXFHTTE-UHFFFAOYSA-N 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000375 suspending agent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- VIVYBCKORJTEEV-UHFFFAOYSA-L zinc;2-carboxyphenolate;trihydrate Chemical compound O.O.O.[Zn+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O VIVYBCKORJTEEV-UHFFFAOYSA-L 0.000 claims description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052726 zirconium Inorganic materials 0.000 claims description 3
- DIZPMCHEQGEION-UHFFFAOYSA-H Aluminium sulfate Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 2
- 101700033614 COR2 Proteins 0.000 claims description 2
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 claims description 2
- 101710008836 UQCRC2 Proteins 0.000 claims description 2
- 229940029983 VITAMINS Drugs 0.000 claims description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims description 2
- DVBBEGGVSYJLME-UHFFFAOYSA-N aluminum;hydrochloride Chemical compound [Al].Cl DVBBEGGVSYJLME-UHFFFAOYSA-N 0.000 claims description 2
- 230000000111 anti-oxidant Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000000022 bacteriostatic agent Substances 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 2
- 230000003020 moisturizing Effects 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- 239000003605 opacifier Substances 0.000 claims description 2
- 230000002335 preservative Effects 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- KGZQYBDYTGNDSC-UHFFFAOYSA-A tetraaluminum;zirconium(4+);trichloride;tridecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Zr+4] KGZQYBDYTGNDSC-UHFFFAOYSA-A 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamins Natural products 0.000 claims description 2
- WVPIJCZOORWURH-UHFFFAOYSA-N [Al].Cl.Cl Chemical compound [Al].Cl.Cl WVPIJCZOORWURH-UHFFFAOYSA-N 0.000 claims 1
- IIVZMHCKAQPLIV-UHFFFAOYSA-J aluminum;tetrachlorozirconium Chemical compound [Al+3].Cl[Zr](Cl)(Cl)Cl IIVZMHCKAQPLIV-UHFFFAOYSA-J 0.000 claims 1
- 239000000490 cosmetic additive Substances 0.000 claims 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 claims 1
- 239000000047 product Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 8
- 239000004005 microsphere Substances 0.000 description 6
- 229960003500 triclosan Drugs 0.000 description 6
- 210000004243 Sweat Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004698 Polyethylene (PE) Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229940100530 ZINC RICINOLEATE Drugs 0.000 description 3
- GAWWVVGZMLGEIW-GNNYBVKZSA-L Zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L Zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- 235000012216 bentonite Nutrition 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 238000001033 granulometry Methods 0.000 description 3
- 230000002209 hydrophobic Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 150000003751 zinc Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- LPEPZBJOKDYZAD-UHFFFAOYSA-N Flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Resveratrol Natural products C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N Triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 2
- 229940091251 Zinc Supplements Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting Effects 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N oxo-oxoalumanyloxy-[oxo(oxoalumanyloxy)silyl]oxysilane;dihydrate Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- UFHJEZDFEHUYCR-YUMQZZPRSA-N (2S,3S)-2,3-bis(2,2-dimethylpropanoyloxy)butanedioic acid Chemical compound CC(C)(C)C(=O)O[C@H](C(O)=O)[C@@H](C(O)=O)OC(=O)C(C)(C)C UFHJEZDFEHUYCR-YUMQZZPRSA-N 0.000 description 1
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-Dichloroethene Chemical compound ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-Difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-Methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-Ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- UVSHZSVDEWHXMF-UHFFFAOYSA-N 2-hydroxy-N-(3,4,5-trichlorophenyl)benzamide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC(Cl)=C(Cl)C(Cl)=C1 UVSHZSVDEWHXMF-UHFFFAOYSA-N 0.000 description 1
- YURFJRIDNKGUDV-UHFFFAOYSA-N 3,7,11-trimethyldodeca-2,5,10-trien-1-ol Chemical compound CC(C)=CCCC(C)C=CCC(C)=CCO YURFJRIDNKGUDV-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960003260 Chlorhexidine Drugs 0.000 description 1
- 229960001884 Chlorhexidine diacetate Drugs 0.000 description 1
- 240000003412 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 229940102552 DISTEARDIMONIUM HECTORITE Drugs 0.000 description 1
- 229940073551 DISTEARYLDIMONIUM CHLORIDE Drugs 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 210000003298 Dental Enamel Anatomy 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N Dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M Dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-YFVJMOTDSA-N Farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- 229940043259 Farnesol Drugs 0.000 description 1
- 229960004369 Flufenamic Acid Drugs 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- NNPPMTNAJDCUHE-UHFFFAOYSA-N Isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 1
- 229940058690 Lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N Lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-DFHJLLNLSA-N Lanosterol Natural products C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@]21C CAHGCLMLTWQZNJ-DFHJLLNLSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Monolaurin Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- UBZMVKPSTPGQMK-UHFFFAOYSA-N N,N'-dibutyl-N'-dodecylbutanediamide Chemical compound CCCCCCCCCCCCN(CCCC)C(=O)CCC(=O)NCCCC UBZMVKPSTPGQMK-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229940057981 STEARALKONIUM CHLORIDE Drugs 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229940005581 Sodium Lactate Drugs 0.000 description 1
- 229940045875 Sodium pidolate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M Stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N Trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 240000008529 Triticum aestivum Species 0.000 description 1
- 241000282495 Vulpes corsac Species 0.000 description 1
- 229940050168 ZINC LACTATE Drugs 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229960000306 Zinc Gluconate Drugs 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 229940118827 Zinc phenolsulfonate Drugs 0.000 description 1
- BDWVCGRBLZEHPU-UHFFFAOYSA-N [Al].Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.[Zr] Chemical compound [Al].Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.[Zr] BDWVCGRBLZEHPU-UHFFFAOYSA-N 0.000 description 1
- JPSPFSUKIGFWQS-UHFFFAOYSA-N [Al].Cl.Cl.Cl.Cl.[Zr] Chemical compound [Al].Cl.Cl.Cl.Cl.[Zr] JPSPFSUKIGFWQS-UHFFFAOYSA-N 0.000 description 1
- HYTNKIWSENKYSO-UHFFFAOYSA-N [Al].ClOCl Chemical compound [Al].ClOCl HYTNKIWSENKYSO-UHFFFAOYSA-N 0.000 description 1
- WDRFFJWBUDTUCA-UHFFFAOYSA-N [amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]-[6-[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]azaniumylhexyl]azanium;diacetate Chemical compound CC(O)=O.CC(O)=O.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WDRFFJWBUDTUCA-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 230000002576 anti-transpirant Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- RGOLHHQRNQPCOF-UHFFFAOYSA-N decanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.CCCCCCCCCC(O)=O RGOLHHQRNQPCOF-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N diguanide Chemical class NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- KARVSHNNUWMXFO-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate Chemical class O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O KARVSHNNUWMXFO-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BHBPJIPGXGQMTE-UHFFFAOYSA-N ethane-1,2-diol;2-methylprop-2-enoic acid Chemical compound OCCO.CC(=C)C(O)=O.CC(=C)C(O)=O BHBPJIPGXGQMTE-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-M gallate Chemical compound OC1=CC(C([O-])=O)=CC(O)=C1O LNTHITQWFMADLM-UHFFFAOYSA-M 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000011528 polyamide (building material) Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- CJGOMTUOQIGPNI-UHFFFAOYSA-N propane-1,2-diol;hydrochloride Chemical compound Cl.CC(O)CO CJGOMTUOQIGPNI-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- CRPCXAMJWCDHFM-DFWYDOINSA-M sodium;(2S)-5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)[C@@H]1CCC(=O)N1 CRPCXAMJWCDHFM-DFWYDOINSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940070720 stearalkonium Drugs 0.000 description 1
- 125000005502 stearalkonium group Chemical group 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000021307 wheat Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- CHCZPSBPZFXDQJ-UHFFFAOYSA-L zinc;2-oxopyrrolidine-1-carboxylate Chemical compound [Zn+2].[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O CHCZPSBPZFXDQJ-UHFFFAOYSA-L 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
Abstract
The present invention is related to a cosmetic deodorant composition, which comprises at least:a) zinc salicylate or a derivative thereof, and b) an antiperspirant aluminum salt, where the zinc salicylate and the aluminum salt are present in a weight ratio of from about 1:500 to about 10:1, and preferably from about 1:200 to about 1:1. The invention further refers to a cosmetic process for treating human perspiration and human axillary odours by using the present composition.
Description
DEODORANT COSMETIC COMPOSITION COMPRISING THE ASSOCIATION OF ZINC SALICILATE OR ONE OF ITS DERIVATIVES AND A SALT OF
ANTI-TRANSPIRANT ALUMINUM.
DESCRIPTION OF THE INVENTION The invention has for its object a deodorant cosmetic composition comprising at least: a) zinc salicylate or one of its derivatives, in free or hydrated form and b) at least one anti-perspirant aluminum salt; the weight ratio zinc salicylate / aluminum salt oscillating between 1/500 and 10/1 and preferably between 1/200 and 1/1. The invention also relates to a method of cosmetic treatment of human perspiration and human axillary odors with the aid of this composition. The invention relates to the use of the combination of zinc salicylate or one of its derivatives and of an antiperspirant aluminum salt as an active deodorant in a cosmetic composition. In the cosmetic field, it is well known to use topical application deodorants containing active substances of the antiperspirant type of bactericidal or odor-absorbing type to reduce, Ref. 169061
even suppress, usually unpleasant axillary odors. Bactericidal substances inhibit the development of the cutaneous flora responsible for axillary odors. They have the disadvantage of not being active on the smell of sweat already developed. Among the bactericidal products, the most commonly used is Triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether), which has the disadvantage of significantly modifying the ecology of the cutaneous flora, of being inhibited by certain compounds , such as, for example, nonionic surfactants, currently used in the formulation of cosmetic compositions. On the other hand, the insoluble nature of Triclosan in water does not allow its incorporation into essentially aqueous formulas. The anti-perspirant substances have the effect of limiting the sudoral flow. They are generally constituted by aluminum salts. Its deodorant effectiveness is limited when used alone. In addition, at high concentrations, these substances have a potential irritant to the skin. Among the deodorant active agents, some water-soluble zinc salts have already been proposed in deodorant products such as, for example, zinc pyrrolidone carboxylate (more commonly known as sodium pidolate).
zinc), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate and zinc phenolsulfonate. Such deodorant formulations have been particularly described in documents 093/01793, EP468564, EP024176 and EP768080. In the 1930s as described in particular the work Drugs & Cosmetic lndustry-Modern Cosmetics; Chapter Deodorants pages 168-177 (1934), it was known that zinc salicylate could be formulated in paste-type deodorant or bar-form formulations in the necessary presence of other active agents for sufficient deodorant action. It has been proposed more recently as a possible deodorant active agent in different supports, according to the patent EP318206 in bar gels based on becilidene sorbitol, an emollient of the di-isopropyladipate type, one or more polar solvents and a coupling agent; according to patents US 5,254,332 and US 5,302,381 in bars containing a volatile silicone oil, a low melting point wax, an emollient insoluble in liquid water and in the presence of a deodorant active agent of the sodium bicarbonate type; according to application 002/1 3776 in aqueous gels based on fatty acid soaps. However, the effectiveness of its zinc salts is limited when used alone. To allow to increase the deodorant efficiency,
Different associations of active agents have been proposed. In patent application 097/24131, it has been proposed to associate zinc salicylate with an acylglycine
US Pat. No. 6,426,061 also known compositions for combating the development of human skin perspiration odors comprising the association of the following active agents: (1) an androgen receptor inhibitor (resveratrol, epigallocatechin-3-) gallate or flufenamic acid); (2) an active anti-DHT agent (zinc salts in particular zinc sulfate) (3) an inhibitor of odor-carrying proteins, (4) an anti-perspirant aluminum salt and (5) an antimicrobial agent of the type chlorhexidine digluconate or chlorhexidine diacetate. These compositions have the disadvantage of using particularly active antimicrobial agents on the cutaneous flora. It is known from patent application O01 / 52804 deodorant compositions based on antiperspirant salts to which it is proposed to add transition metal chelators (DPTA). These formulations are potentially ecotoxic. In the patent application EP1486199, alcohol-based aerosol compositions have been described.
zinc salicylate or one of its derivatives. Although it is generally described, in this application, the possibility of associating antiperspirant salts, the applicant has observed that in particular relative amounts the deodorant efficacy obtained was insufficient. The object of the present invention is therefore to have new cosmetic compositions comprising a deodorant system with an efficiency superior to that of the anti-perspirant salts and that of the zinc salicylate salts used alone and which do not have the disadvantages of the same. deodorant products of the prior art as mentioned above. The Applicant has discovered that a composition of this type was obtained using the association of zinc salicylate or one of its derivatives and of an anti-perspirant aluminum salt in a weight ratio zinc salicylate / aluminum salt ranging from 1 / 500 and 10/1 and preferably between 1/200 and 1/1. The applicant firm has unexpectedly discovered that this particular association had a synergistic effect at the level of the decrease in odor intensity in relation to the active agents used individually. More specifically, the invention relates to a deodorant cosmetic composition comprising at least: a) zinc salicylate or one of its derivatives, in
free or hydrated form and b) at least one anti-perspirant aluminum salt; the weight ratio zinc salicylate / aluminum salt oscillating between 1/500 and 10/1 and preferably between 1/200 and 1/1. The invention also relates to a method of cosmetic treatment of human perspiration and human axillary odors with the aid of this composition. The invention relates to the use of the association of zinc salicylate or one of its derivatives and of an antiperspirant aluminum salt as deodorant active agent in a cosmetic composition; in a weight ratio zinc salicylate / aluminum salt ranging between 1/500 and 10/1 and preferably between 1/200 and l / l. In the sense of the present invention, "deodorant composition" is understood to mean any composition capable of reducing sudoral flow, hiding, absorbing, improving and / or reducing the unpleasant odor resulting from the decomposition of human sweat by bacteria. "Anti-perspirant aluminum salt" means any salt or aluminum complex that has the effect of reducing or limiting the sudoral flow. The aluminum salts according to the invention are preferably chosen from aluminum halohydrates;
the aluminum and zirconium halohydrates, the zirconium hydroxychloride and aluminum hydroxychloride complexes with or without an amino acid such as those described in US Pat. No. 3,798,2068. Among the aluminum salts, mention may be made in particular of aluminum chlorohydrate in activated or non-activated form, aluminum chlorohydrex, aluminum complex chlorhydrex polyethylene glycol, aluminum complex hydrochloride propylene glycol, aluminum dichlorohydrate, aluminum complex dichlorhydrex polyethylene glycol , the aluminum complex dichlorhydrex propylene glycol, the aluminum sesquichlorhydrate, the aluminum complex sesquiclorhidrex polyethylene glycol, the aluminum complex sesquiclorhidrex propilenglicol, the aluminum sulfate buffered by sodium lactate and aluminum. Among the aluminum and zirconium salts, mention may be made in particular of aluminum zirconium octahydrochloride, aluminum zirconium pentachlorhydrate, aluminum zirconium tetrahydrochloride, aluminum zirconium trichlorohydrate. Complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid are generally known under the name ZAG (when the amino acid is glycine). Among these products we can mention the complexes of aluminum zirconium octachlorhydrex glycine, aluminum zirconium pentachlorhydrex glycine, aluminum
zirconium tetrachlorhydrex glycine and aluminum zirconium trichlorhydrex glycine. Aluminum hydrochloride in activated or non-activated form will be used more particularly. The antiperspirant aluminum salts may be present in the composition according to the invention in a proportion of about 0.5 to 25% by weight relative to the total weight of the composition. The zinc salicylate and its derivatives according to the invention respond in general to the following structure:
wherein n = 2, p equals 0, 1, 2 or 3; Ri denotes a linear or branched CX-L alkyl (for example methyl, ethyl, n-propyl, isopropyl, n-butyl); a hydroxyalkyl radical of C_-C _, linear or branched; a halogen atom (for example iodine, bromine, chlorine); a C2-C18 acyl radical (for example acetyl); a radical COR2, OCOR2 or C0NHR2 where R2 denotes a hydrogen atom or a linear or branched C? -C? 8 alkenyl radical. More preferably, zinc salicylate (p = 0) and more particularly in hydrated form such as zinc salicylate trihydrate such as the commercial product sold under Zinc Salicylate Trihydrate "will be chosen.
Bernardy Chimie Society. In the compositions of the invention, the concentration in zinc salicylate varies preferably from
0. 001 to 20%, more preferably 0.01 to 15% and even more preferably 0.05 to 5% by weight relative to the total weight of the composition. The deodorant compositions according to the invention intended for cosmetic use can be presented in the form of lotions, creams or fluid gels distributed in an aerosol spray, in an atomizer or in a roll-on, in the form of thick creams distributed in tubes or in a grid; in the form of bars (sticks), and contain in this respect the ingredients generally used in this type of products and well known to the person skilled in the art, with the proviso that they do not interfere with the aluminum salt and the zinc salicylate described in the present invention. Preferably, it will be avoided to condition the compositions according to the invention in an alcoholic aerosol device insofar as the aluminum salt / C_-C4 alcohol / aerosol conditioning mixture has a tendency to cause either degradation of the composition or corrosion of the composition. the aerosol containers, or a loss of effectiveness of the antiperspirant active agent. According to a preferential form, the composition is different from an alcoholic aerosol composition.
By "alcohol aerosol composition" is meant any formulation comprising at least one propellant and at least one mono-C 4 -C alcohol such as propanol, ethanol or isopropanol. The deodorant compositions according to the invention intended for cosmetic use may comprise at least one aqueous phase. They are particularly formulated in aqueous lotions or water-in-oil, oil-in-water, or multiple emulsion emulsions (oil-in-water-in-oil or water-in-oil-in-water emulsion) emulsions are known and described for example by C. FOX in "Cosmetics and Toiletries" - November 1986 - Vol 101 - pages 101-112.) The aqueous phase of the said compositions contains water and in general other solvents soluble or miscible in water. Water-soluble or water-miscible solvents comprise short-chain monohydric alcohols, for example C4-C4 such as ethanol, isopropanol, diols or polyols such as ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol. , hexylene glycol, diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethylether, triethylene glycol monomethyl ether and sorbitol, and propylene glycol and glycerin will be used more particularly, according to a particular form of the invention, Antiperspirants can be anhydrous.
By "anhydrous", it is understood in the sense of the invention, a composition whose content in free or added water is less than 3% and preferably whose added water content is less than 1% by weight with respect to the total weight of the water. The compositions according to the invention preferably comprise at least one organic liquid phase which is immiscible with water, it generally comprises one or more hydrophobic compounds which make the said phase water-immiscible, the indicated phase being liquid (in the absence of an agent). structuring) at room temperature (20-25 ° C) .Preferentially, the organic water-immiscible liquid organic phase according to the invention is generally constituted by an oil or mixture of oils and comprises at least 80% of compounds with a pressure vapor not exceeding 4 kPa (30 mm Hg) at 25 ° C. The organic liquid phase which is immiscible with water preferably contains one or more silicone or hydrocarbon emollients, volatile or non-volatile. These emollient oils are particularly described in US Patents 4,822,596 and 4,904,463. Volatile silicones are defined in a manner known as volatile compounds at room temperature. Mention may be made, among these compounds, of the cyclic and linear volatile silicones of the dimethylsiloxane type whose chains
They comprise from 3 to 9 siliconized waste. Preferably cyclomethicones D, D5 or D are selected. Non-volatile silicones are defined in a known manner as low vapor pressure compounds at room temperature. These compounds include: polyalkylsiloxanes, in particular linear polyalkylsiloxanes, such as linear polydimethylsiloxanes, or dimethicones, marketed by the Dow Corning Company under the name "Dow Corning 245 Fluid"; polyalkylaryl siloxanes, such as, for example, polymethylphenylsiloxanes, marketed by the Dow Corning Company under the name "Dow Corning 556 Fluid"; polyether and siloxane copolymers, such as, for example, dimethicone copolyols. Among the non-volatile emollient oils which can be used in the present invention, there may be mentioned, for example: hydrocarbon derivatives, mineral oils, fatty alcohols, esters of C3-C_8 alcohols with C3-C18 acids, benzoic acid esters with C2-C18 alcohols and mixtures thereof, C2-C6 polyols selected preferably from glycerol, propylene glycol or sorbitol, polyalkylene glycol polymers. Emollient oils are preferably present in amounts ranging from 1 to 50% by weight and more
preferably from 5 to 40% by weight relative to the total weight of the composition. The deodorant cosmetic composition according to the invention may contain one or more additional deodorant active agents such as for example bacteriostatic agents or bactericidal agents such as 2,4,4'-trichloro-2'-hydroxydiphenylether (Triclosan), 2,4-dichloro -2 '-hydroxydiphenylether, 3', 4 ', 5'-trichlorosalicylanilide, 1- (3', 4'-dichlorophenyl) -3- (4'-chlorophenyl) urea (Triclocarban) or 3, 7, ll -trimethyldodeca-2, 5, 10-trienol (Farnesol); quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts; chlorhexidine and salts; the diglycerol monocaprate, the diglycerol monolaurate, the glycerol monolaurate; the polyhexamethylene biguanidine salts. In order to improve the homogeneity of the product, it is also possible to use one or more suspension agents which are preferably selected from hydrophobic modified montmorillonite clays such as bentonites or hydrophobic modified hectorites. Mention may be made, for example, of the product Stearalkonium Bentonite (name CTFA) (reaction product of bentonite and quaternary ammonium stearalkonium chloride) such as the commercial product sold under the name TIXOGEL MP 250 by the Sud Society CHEMIE Rheologicals, United Catalyts Inc or the product
Disteardimonium Hectorite (name CTFA) (reaction product of hectorite and distearyldimonium chloride) sold under the name of Bentone 38 or Bentone Gel by the Elementies Specialties Company. The suspending agents are preferably present in amounts ranging between 0.1 and 5% by weight and more preferably between 0.2 and 2% by weight relative to the total weight of the composition. The compositions according to the invention can also contain at least one organic powder. Among the fillers which can be used according to the invention, organic powders can be mentioned. In the present application, the term "organic powder" means any solid insoluble in the medium at room temperature (25 ° C). As organic powders that can be used in the composition of the invention, mention may be made, for example, of the polyamide particles and particularly those sold under the names ORGASOL by the Atochem Company; polyethylene powders; microspheres based on acrylic copolymers, such as those of copolymer ethylene glycol dimethacrylate / lauryl methacrylate sold by the Dow Corning Company under the name of POLYTRAP; the polymethyl methacrylate microspheres, marketed under the name MICROSPHERE M-100 by the Matsumoto company or under the name COVABEAD LH85 by the
Society ackherr; ethylene-acrylate copolymer powders, such as those marketed under the name FLOBEADS by the Company Suika Seika Chemicals; expanded powders such as hollow microspheres and in particular, microspheres formed by a terpolymer of vinylidene chloride, acrylonitrile and methacrylate and marketed under the name EXPANCEL by the company emanord Plast under references 551 DE 12 (granulometry of approximately 12 μm and mass volume 40 kg / m3), 551 DE 20 (granulometry of approximately 30 μm and density of 65 kg / m3), 551 DE 50 (granulometry of approximately 40 μm), or microspheres marketed under the name MICROPEARL F 80 ED by the Company Matsumoto; powders of natural organic materials such as starch powders, particularly corn, wheat or rice starches, crosslinked or not, such as starch powders crosslinked by octenyl succinate anhydride, marketed under the name DRY-FLO by the Company National Starch; silicone resin microbeads such as those marketed under the name TOSPEARL by the Toshiba Silicone Company, particularly TOSPEARL 240; amino acid powders such as the Lauroillisin powder marketed under the name AMIHOPE LL-11 by the Ajinomoto Society; the wax microdispersion particles, which preferably have lower average dimensions
at 1 μm, and consisting essentially of a wax or a mixture of waxes, such as the products marketed under the name Aquacer by the Byk Cera Company, and in particular: Aquacer 520 (mixture of synthetic and natural waxes), Aquacer 514 or 513 (polyethylene wax), Aquacer 511 (polymer wax), or such as the products marketed under the name Jonwax 120 by the company Jonson Polymer (mixture of polyethylene and paraffin waxes) and under the name Ceraflour 961 by the Company Byk Wax (micronized modified polyethylene wax); and its mixtures. The cosmetic composition according to the invention may further comprise cosmetic adjuvants selected from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizing agents, vitamins, perfumes, bactericides, preservatives, polymers, perfumes, Thickening agents, propellants or any other ingredient commonly used in cosmetics for this type of application. Of course, the person skilled in the art will try to choose this or these possible complementary compounds in such a way that the advantageous properties intrinsically related to the cosmetic composition according to the invention are not, or substantially, altered by the addition (s) considered.
The waxes can be chosen from animal, fossil, vegetable, mineral or synthetic waxes. Mention may be made in particular of beeswax, Carnauba, Candelilla, sugarcane, Japan, ozokerite waxes, Montan wax, microcrystalline waxes, paraffins, waxes and silicone resins. The thickeners, preferably non-ionic, can be chosen from guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum, cetylhydroxyethylcellulose, silicas such as Bentona Gel MIÓ sold by the NL INDUSTRIES Company or the Veegum Ultra, sold by the Society POLYPLASTIC. The amounts of these different constituents that may be present in the cosmetic composition according to the invention are those conventionally used in deodorant compositions. The compositions according to the invention may also contain one or more other structuring or gelling agents of the water-immiscible organic liquid phase of the composition, such as linear solid fatty alcohols and / or waxes; fatty acids or their salts (stearic acid, sodium stearate, 12-hydroxystearic acid); the dibenzylidene alditols (DBS); lanosterol, the N-acyl amino acid derivatives; the derivatives of di or triacidos
carboxylics such as alkyl N, N '-dialkylsuccinamides (ie: dodecyl N, N'-dibutylsuccinamide); the organopolysiloxane elastomers such as those described in the application 097/44010. The composition according to the invention can also be pressurized and conditioned in an aerosol device. The present invention relates to an aerosol device consisting of: (A) a container comprising a deodorant composition as defined above,
(B) at least one propellant and a means of distributing said aerosol composition. The propellants generally used in this type of products and well known to those skilled in the art are, for example, dimethyl ether (DME); volatile hydrocarbons such as n-butane, propane, isobutane, and mixtures thereof, optionally with at least one gold and / or fluorinated hydrocarbon; among the latter, mention may be made of the compounds sold by the Dupont de Nemours Company under the names Fréon® and Dymel®, and in particular monofluorotrichloromethane, difluorodichloromethane, tetrafluorodichloroethane and 1,1-difluoroethane, sold in particular under the trade name DYM? L 152 A by the DUPONT Company. It can also be used as
propellant agent carbon dioxide, nitrous oxide, nitrogen or compressed air. The composition containing the deodorant active agent (s) and the propellant (s) may be in the same compartment or in different compartments in the aerosol container. According to the invention, the concentration in propellant agent generally ranges from 5 to 95% by weight pressurized and more preferably from 50 to 85% by weight relative to the total weight of the pressurized composition. The distribution means, which forms a part of the aerosol device, is generally constituted by a dispensing valve actuated by a dispensing head, the latter comprising a nozzle by means of which the aerosol composition is vaporized. The container containing the pressurized composition may be opaque or transparent. It can be made of glass, polymeric material or metal, possibly coated with a layer of protective enamel. The subject of the present invention is also a cosmetic process for treating human axillary odors, which consists in applying an effective amount of a composition as defined above to the axillary surface. The examples that follow serve to illustrate the
present invention.
1 / Comparison of the deodorant activity of the zinc salicylate / aluminum salt association in relation to the associations of triclosan / aluminum salt and zinc ricinoleate / aluminum salt. Deodorant efficacy test protocol. sauna with 6 volunteers, samples of individual sweat, kept on ice for a few hours, are then practically odorless. Next, 1 ml aliquots were mixed and divided into aliquots. The active agents were added to these aliquots, then they were incubated in an oven at 37 ° C. After 24 hours of incubation, a jury of experts evaluated the odor intensity compared to a control sample: 1 ml of sweat incubated without active agent contribution. The intensity was evaluated on a scale of 0 (no odor) to 4 (very strong odor). The results are expressed in% variation of odor intensity compared to this sample of control sweat (mean of% variation at T24h). / - intensity odor intensity - odor intensity of the sample shows control with active agent? = x 100 intensity smell of the control sample
ACH: Aluminum Chlorohydrate (Micro Dry - Reheis) (A): Zinc Salicylate (Bernardy Chimie) (B): Triclosan (CIBA) (C): Zinc Ricinoleate (Grillo Werke) It is observed that the zinc salicylate / aluminum salt (weight ratio: l / l) led to a synergy effect at the level of the decrease in odor intensity contrary to the Triclosan / aluminum salt and zinc ricinoleate / aluminum salt associations.
Example 1; Deodorant bar
Cyclopentasiloxane was heated to 65 ° C. The other ingredients were added (1 by 1) remaining at 65-70 ° C. The whole (transparent solution) was homogenized for 15 minutes. The 2 deodorant active agents and the talc were added. It was refrigerated at about 55 ° C (a few degrees Celsius above the thickening of the mixture) and slipped into the bars. They were placed at 4 ° C for 30 minutes.
Example 2; Roll-on (emulsion)
Phases (B) and (C) were heated separately at 70 ° C. Mixed (B) and (C) under Turax 5 mm agitation then cooled to 55 ° C under shovel. A was added gently under agitation. It was homogenized for 1 to 3 minutes. It was allowed to cool to 35 ° C under stirring. The formula is stable 2 months at 45 ° C.
Example 3; Non-aerosol spray (Emulsion obtained by phase inversion)
The gluconate was solubilized in water and added to the
Emulgade CM under moderate agitation. The aluminum salt solution was added under moderate agitation. The formula is stable 2 months at 45 ° C. It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Claims (32)
1. Cosmetic deodorant composition, characterized in that it comprises at least: a) zinc salicylate or one of its derivatives, in free or hydrated form, - b) an anti-perspirant aluminum salt; oscillating the weight ratio zinc salicylate / aluminum salt between 1/500 and 10/1.
Composition according to claim 1, characterized in that the weight ratio of zinc salicylate / aluminum salt varies from 1/200 to 1/1.
Composition according to claim 1 or 2, characterized in that the antiperspirant salt is chosen from the aluminum halohydrates; the aluminum and zirconium halohydrates; complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid.
Composition according to claim 3, characterized in that the antiperspirant aluminum salt is selected from aluminum chlorohydrate in activated or non-activated form, aluminum hydrochloride, the complex of aluminum chlorhydrex polyethylene glycol, the complex of aluminum chlorhydrex propylene glycol, aluminum dihydrochloride, the aluminum complex dichlorhydrex polyethylene glycol, the aluminum complex dichlorhydrex propylene glycol, the aluminum sesquichlorhydrate, the aluminum complex sesquiclorhidrex polyethylene glycol, the aluminum complex sesquiclorhidrex propylene glycol, the aluminum sulfate aluminum buffered by sodium and aluminum lactate.
Composition according to claim 3, characterized in that the antiperspirant aluminum salt is chosen from aluminum zirconium octachloride, zirconium aluminum pentachloride, aluminum zirconium tetrachloride, aluminum zirconium trichlorohydrate.
6. Composition in accordance with the claim 3, characterized in that the antiperspirant aluminum salt is selected from the complexes of zirconium hydroxychloride and aluminum hydroxychloride with glycine.
Composition according to claim 6, characterized in that the antiperspirant aluminum salt is selected from aluminum complexes of zirconium octachlorhydrex glycine, zirconium aluminum pentachlorhydrex glycine, aluminum zirconium tetrachlorhydrex glycine and aluminum zirconium trichlorhydrex glycine.
8. Composition in accordance with any of the previous claims, characterized in that the antiperspirant aluminum salt is aluminum chlorohydrate in activated or non-activated form.
Composition according to any one of claims 1 to 8, characterized in that the antiperspirant aluminum salt or salts are present in amounts ranging from 0.5 to 25% by weight relative to the total weight of the composition.
10. Composition according to any of claims 1 to 9, characterized in that the zinc salicylate or one of its derivatives are selected from the following compounds of formula (1): wherein n = 2, p equals 0, 1, 2 or 3; R x denotes a linear or branched Ci-Cis alkyl; a hydroxyalkyl radical of Cx-Cie, linear or branched; a halogen atom; an acyl radical of C2-C ?3 a group COR2, OCOR2 or CONHR2 where R2 denotes a hydrogen atom or a straight or branched Cx-Cis alkyl radical.
11. Composition according to claim 10, characterized in that the compound of formula (I) is zinc salicylate (p = 0).
12. Composition according to claim 11, characterized in that the compound of formula (I) is zinc salicylate trihydrate.
13. Composition according to any of claims 1 to 12, characterized in that the concentration in zinc salicylate varies from 0.001 to 20%, preferably from 0.01 to 15% and also preferably from 0.05 to 15%. 5% by weight relative to the total weight of the composition.
14. Composition according to any of claims 1 to 13, characterized in that it is in the form of a lotion, cream or gel fluid distributed in an aerosol spray, in an atomizer or in a roll-on; in the form of a cream or gel distributed in a tube or in a grid; in the form of a bar (stick)
15. Composition according to any of the preceding claims, characterized in that it is different from an alcoholic aerosol composition.
16. Composition according to any of the preceding claims, characterized in that it comprises at least one aqueous phase.
Composition according to claim 16, characterized in that it is in the form of an aqueous lotion, in the form of a water-in-oil, oil-in-water emulsion; in the form of multiple emulsion.
18. Composition in accordance with claim 17, characterized in that the aqueous phase contains water and one or more solvents soluble or miscible in water.
Composition according to claim 18, characterized in that the solvents soluble or miscible in water are selected from the mono alcohols of C _.- C the diols; the polyols.
20. Composition according to any of claims 1 to 14, characterized in that it is anhydrous.
21. Composition according to any of claims 1 to 20, characterized in that it comprises at least one organic liquid phase not miscible with water.
22. Composition according to claim 21, characterized in that the organic liquid phase comprises one or more silicone or hydrocarbon emollient oils, volatile or non-volatile.
23. Composition according to claim 22, characterized in that the emollient oils are present in amounts ranging from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the total weight of the composition.
24. Composition according to any of claims 1 to 23, characterized in that it also comprises one or more additional deodorant active agents.
25. Composition in accordance with claim 24, characterized in that it also comprises one or more bacteriostatic agents or bactericidal agents.
26. Composition according to any of claims 1 to 25, characterized in that it also comprises one or more suspending agents.
Composition according to any of claims 1 to 26, characterized in that it also comprises at least one organic powder.
Composition according to any one of Claims 1 to 27, characterized in that it also comprises at least one cosmetic additive selected from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizing agents, vitamins, perfumes, bactericides, preservatives, polymers, perfumes, thickeners, propellants.
Composition according to any of claims 21 to 28, characterized in that it also comprises one or more structuring or gelling agents of the organic liquid phase not miscible with water.
30. Aerosol device, characterized in that it is constituted by: (A) a container comprising a deodorant composition according to any one of claims 1 to 29. (B) at least one propellant and a means of distributing said aerosol composition.
31. A cosmetic procedure for treating human axillary odors, characterized in that it consists in applying an effective amount of a composition according to any one of claims 1 to 29 to the axillary surface.
32. Use of the zinc salicylate or one of its derivatives and an antiperspirant aluminum salt according to any one of the preceding claims in a weight ratio zinc salicylate / aluminum salt ranging from 1/500 to 10/1, according to any one of the claims above as deodorant active agent in a cosmetic composition.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0550991 | 2005-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06003464A true MXPA06003464A (en) | 2006-12-13 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7326409B2 (en) | Deodorant cosmetic composition comprising a combination of zinc pidolate and an antiperspirant aluminum salt | |
JP6001051B2 (en) | Cosmetic method for treating human body odor using 4- (3-ethoxy-4-hydroxyphenyl) alkylketone compound or 2-ethoxy-4-hydroxyalkylphenol compound | |
EP1877033B1 (en) | Deodorant cosmetic composition comprising a combination of a lipophilic salicylic acid derivative and an antiperspirant aluminium salt | |
MX2007006144A (en) | Underarm cosmetic method and compositions. | |
JP2003507402A (en) | Compositions containing solubilized acid-enhancing forced sweat actives | |
BRPI0904268A2 (en) | cosmetic process of perfuming a keratically human matter, aqueous perfuming composition, compositions and cosmetic process of treatment of body odors | |
AU734796B2 (en) | Antiperspirant or deodorant compositions | |
ES2325841T3 (en) | HYDROALCOHOLIC DEODORANT COMPOSITION CONTAINING A ZINC HYDROSOLUBLE SALT AND SALICILIC ACID. | |
ES2372175T3 (en) | ANTITRANSPIRING COMPOSITIONS CONTAINING VASELINE. | |
ES2288732T3 (en) | ANTI-TRANSPIRANT COMPOSITION OF WATER EMULSION TYPE IN WATER CONTAINING WAX MICROPARTICLES. | |
MXPA04012279A (en) | Deodorant cosmetic composition comprising a combination of zinc gluconate and an antiperspirant aluminum salt. | |
AU2015202609B2 (en) | Aerosol deodorant antiperspirant compositions | |
EP1714638A1 (en) | Cosmetic deodorant composition comprising a combination of zinc salicylate or a derivative thereof with an aluminium salt antiperspirant active | |
ES2360057T3 (en) | COSMETIC DEODORANT COSTUMPTION CONTAINING THE ASSOCIATION OF ZINC PIDOLATE AND ANTI-TRANSPIRANT ALUMINUM SALT. | |
US7332154B2 (en) | Deodorant cosmetic composition comprising a combination of zinc gluconate and an antiperspirant aluminum salt | |
US20070031526A1 (en) | Topical Deodorant Compositions Based on Hydroxycitric Acid | |
MXPA06003464A (en) | Cosmetic deodorant composition comprising a combination of zinc salicylate or a derivative thereof with an aluminium salt antiperspirant active | |
WO2007031117A1 (en) | Use op a lipophilic salicylic acid derivative as a deodorant active agent, process for treating body odour | |
US20160296428A1 (en) | Aerosol deodorant antiperspirant compositions | |
Giovanniello | Antiperspirants and deodorants |